Skip to main content

Advertisement

Log in

Drug prescription in pregnancy: analysis of a large statutory sickness fund population

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective

To examine the prescription of drugs in Germany prior to, during and after pregnancy.

Methods

For the first time, prescription data of a large cohort of pregnant women, from a German statutory sickness fund, were available for scientific analysis. For each woman who gave birth between June 2000 and May 2001 reimbursed prescriptions for two periods (90 days each) before pregnancy, three during and two after delivery were considered. The drugs were classified according to the ATC code.

Results

Of the 41,293 women, 96.4% received at least one drug during pregnancy. A median of 7 drugs per women was prescribed. Excluding vitamins, minerals, iodide and iron, 85.2% received at least one drug and the median was 3. Magnesium, which was seldom prescribed outside of pregnancy, was by far the most frequently prescribed substance (20% of all prescriptions, 61% of the women). Iron (54% of the women) and iodide (31%) were also prescribed often. The prescription rates of gynaecological antiinfectives (maximum in third trimester: 23% of the women), antacids (max. in third trim.: 11%), as well as antiemetics and antinauseants (max. in first trim.: 8%) during pregnancy considerably increased. A decrease was seen for analgesics, antiinflammatory and antirheumatic drugs, muscle relaxants, ophtalmologicals and anti-acne preparations, for example. Potential teratogenic drugs were prescribed to 1.3% of the women.

Conclusion

This analysis of a large nation-wide cohort of pregnant women showed that during pregnancy drugs were prescribed to most women, even when vitamins, minerals, iodide and iron were omitted. Magnesium and iron seemed to have been over-prescribed. On the other hand, the official recommendation for iodide substitution, to prevent thyroid diseases in mother and child, was insufficiently implemented. In our opinion, regular analysis of prescription data can identify potential harmful therapies and focal points where guidelines are needed and can check their implementation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bonati M, Bortolus R, Marchetti F, Romero M, Tognoni G (1990) Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 38:325–328

    CAS  PubMed  Google Scholar 

  2. Collaborative group on drug use in pregnancy (CGDUP) (1992) Medication during pregnancy: an intercontinental cooperative study. Int J Gynecol Obstet 39:185–196

    Google Scholar 

  3. De Vigan C, De Walle HEK, Cordier S, Goujard J, Knill-Jones R, Aymé S, Calzolari E, Bianchi F, OECM Working Group (1999) Therapeutic drug use during pregnancy: a comparison in four European countries. J Clin Epidemiol 52:977–982

    Article  PubMed  Google Scholar 

  4. Hoffmann A, Jäger O, Peiker G, Reimann I (1992) Drug use in pregnancy: East German data of an international collaborative study. Int J Clin Pharmacol Ther Toxicol 30:462–464

    CAS  PubMed  Google Scholar 

  5. Reimann I, Karpinsky C, Hoffmann A (1996) Epidemiological data on drug use during pregnancy in Thuringia, East Germany, 1993. Int J Clin Pharmacol Ther 34:80–83

    CAS  PubMed  Google Scholar 

  6. Irl C, Hasford J, and the PEGASUS-Study Group (1997) The PEGASUS-project—a prospective cohort study for the investigation of drug use in pregnancy. Int J Clin Pharmacol Ther 35:572–576

    CAS  PubMed  Google Scholar 

  7. Egen V, Roesch C, Steinbicker V, Hasford J (2002) Drug utilization during pregnancy – a comparison between East and West Germany. Pharmacoepidemiol Drug Saf 11:S148–S149

    Google Scholar 

  8. De Jong-van den Berg LTW, Waardenburg CM, Haaijer-Ruskamp FM, Dukes MNG, Wesseling H (1993) Drug use in pregnancy: a comparative appraisal of data collecting methods. Eur J Clin Pharmacol 45:9–14

    PubMed  Google Scholar 

  9. Briggs GG, Freeman RK, Yaffe SJ (2002) Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. Williams and Wilkins, Baltimore

    Google Scholar 

  10. Koren G, Pastuszak A, Ito S (1998) Drugs in pregnancy. NEJM 338:1128–1137

    Article  CAS  PubMed  Google Scholar 

  11. Schwabe U, Ziegler R (2001) Mineralstoffpräparate und Osteoporosemittel. In: Schwabe U, Paffrath D (eds) Arzneiverordnungsreport 2000. Springer, Berlin Heidelberg New York, p 502

    Google Scholar 

  12. World Health Organization (WHO) (1992) Maternal health and safe motherhood programme—nutrition programme. The prevalence of anaemia in women: a tabulation of available information. World Health Organization, Geneva

    Google Scholar 

  13. Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (1993) Ernährung und Stoffwechselfragen in der Schwangerschaft. I. Jodversorgung für Schwangere. Frauenarzt 34:10–12

    Google Scholar 

  14. Grospietsch G (2000) Erkrankungen in der Schwangerschaft: ein Leitfaden mit Therapieempfehlungen für Klinik und Praxis. Wiss. Verl.-Ges., Stuttgart, p 298

    Google Scholar 

  15. Anonymous (1999) Sonstige Hilfen-Richtlinien. Änderung der Sonstige Hilfen-Richtlinien. Dt Ärzteblatt 96:A-231–A-232

    Google Scholar 

  16. Köster I, von Ferber L, Schubert I (1996) Häufigkeit und Umfang der ärztlichen Inanspruchnahme während der Schwangerschaft. Frauenarzt 37:1242–1250

    Google Scholar 

  17. Olesen C, Hald Steffensen F, Lauge Nielsen G, de Jong-van den Berg L, Olsen J, Toft Sorensen H, and The Euromap Group (1999) Drug use in first pregnancy and lactation: a population-based survey among Danish women. Eur J Clin Pharmacol 55:139–144

    Article  CAS  PubMed  Google Scholar 

  18. Malm H, Martikainen J, Klaukka T, Neuvonen J (2003) Prescription drugs during pregnancy and lactation—a Finnish register-based study. Eur J Clin Pharmacol 59:127–133

    PubMed  Google Scholar 

  19. De Jong-van den Berg LTW, van den Berg PB, Haaijer-Ruskamp FM, Dukes MNG, Wesseling H (1991) Investigating drug use in pregnancy. Methodological problems and perspectives. Pharm Weekbl [Sci] 13:32–38

    Google Scholar 

  20. Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL (2000) Prescription of drugs during pregnancy in France. Lancet 356:1735–1736

    Article  CAS  PubMed  Google Scholar 

  21. Beyens MN, Guy C, Ratrema M, Ollagnier M (2003) Prescription of drugs to pregnant women in France: the HIMAGE study. Therapie 58:505–511

    PubMed  Google Scholar 

  22. Statistisches Bundesamt (2002) Statistisches Jahrbuch. Statistisches Bundesamt, p 62

  23. Statistisches Bundesamt (2003) Durchschnittliches Alter der Mütter bei der Geburt ihrer lebendgeborenen Kinder. http://www.destatis.de/basis/d/bevoe/bevoetab2.htm

Download references

Acknowledgements

The study was funded by the Deutsche Forschungsgemeinschaft (DFG) (German Research Foundation), a central, self-governing, research organisation that promotes research at universities and other publicly financed research institutions in Germany (project identification no. 226661). We thank the Techniker Krankenkasse for providing the data and Dr. Günther, Dr. Köthemann and all other persons involved in the project for their very engaged support. We thank J. Kerr, Ph.D., for linguistical revision of the paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Veronika Egen-Lappe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Egen-Lappe, V., Hasford, J. Drug prescription in pregnancy: analysis of a large statutory sickness fund population. Eur J Clin Pharmacol 60, 659–666 (2004). https://doi.org/10.1007/s00228-004-0817-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-004-0817-1

Keywords

Navigation